「isthe first」の検索結果
21件：6～10件目を表示
-
产品开发方针 | 研究与开发 | 千寿制药株式会社
，其中超过10亿人尚未得到必要的治疗。报告还指出，导致全球视觉障碍或失明的主要原因包括 白内障、屈光不正（近视，老视等）、年龄相关性黄斑变性、青光眼、糖尿病视网膜病变等。 为创造针对眼部疾病的高价值（First in Class、Best in Class、 提升患者便利性等）产品，我们将继续全力推进研究开发活动。在产品战略上，我们将“为导致视觉障碍或者失明的眼部疾病做出贡献” 、“满足未满足的医...
http://www.senju.co.jp/chinese/rd/policy/ -
einafter this "Product") from Ministry of Health, Labour and Welfare. This Product is the first eye drop in Japan containing “Brimonidine tartrate”, an ingredient that relieves hyperemia and...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903_0.pdf -
einafter this "Product") from Ministry of Health, Labour and Welfare. This Product is the first eye drop in Japan containing “Brimonidine tartrate”, an ingredient that relieves hyperemia and...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903.pdf -
临床试验信息 | 研究与开发 | 千寿制药株式会社
List of Clinical Trial Summaries ※Listed in order of date of first publication Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Jap...
http://www.senju.co.jp/chinese/rd/trial.html -
Management Policy | About Senju | SENJU Pharmaceutical
;Sen-sen" is our mascot embodying the image of Senju Sense. Its name was created by taking the first syllable of each word in "Senju Sense."
http://www.senju.co.jp/english/about/philosophy.html